Picture of Verve Therapeutics logo

VERV — Verve Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Verve Therapeutics Q2 EPS USD -0.59

Aug 08 (Reuters) - Verve Therapeutics Q2 collaboration revenue USD 6.692
million.
* Q2 net income USD -49.805 million

Recent news on Verve Therapeutics

See all news